TLR4 and breast carcinoma: Importantly, Apetoh et al. reported that patients with breast cancer, who carry at least one TLR4 loss-of-function allele, relapse more quickly after radiotherapy and chemotherapy than those carrying two wildtype TLR4 alleles.